Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Living Cell Microarrays: An Overview of Concepts.

Jonczyk R, Kurth T, Lavrentieva A, Walter JG, Scheper T, Stahl F.

Microarrays (Basel). 2016 May 26;5(2). pii: E11. doi: 10.3390/microarrays5020011. Review.

2.

Implementation of a procalcitonin-guided algorithm for antibiotic therapy in the burn intensive care unit.

Lavrentieva A, Kontou P, Soulountsi V, Kioumis J, Chrysou O, Bitzani M.

Ann Burns Fire Disasters. 2015 Sep 30;28(3):163-70.

3.

Socioeconomic factors and burn. The challenges of poverty and social gradient in our tumultuous world.

Lavrentieva A.

Burns. 2016 Aug;42(5):1022-3. doi: 10.1016/j.burns.2016.04.020. No abstract available.

PMID:
27268008
4.

Determinants of Outcome in Burn ICU Patients with Septic Shock.

Lavrentieva A, Voutsas V, Konoglou M, Karali V, Koukiasa P, Loridas N, Papaioannou M, Vasileiadou G, Bitzani M.

J Burn Care Res. 2016 Mar 18. [Epub ahead of print]

PMID:
27003623
5.

Impact of microparticles derived from erythrocytes on fibrinolysis.

Levin G, Sukhareva E, Lavrentieva A.

J Thromb Thrombolysis. 2016 Apr;41(3):452-8. doi: 10.1007/s11239-015-1299-y.

PMID:
26590996
6.

Aqueous Synthesis of PEGylated Quantum Dots with Increased Colloidal Stability and Reduced Cytotoxicity.

Ulusoy M, Jonczyk R, Walter JG, Springer S, Lavrentieva A, Stahl F, Green M, Scheper T.

Bioconjug Chem. 2016 Feb 17;27(2):414-26. doi: 10.1021/acs.bioconjchem.5b00491.

PMID:
26567697
7.

Being Overweight Is Associated With Greater Survival in ICU Patients: Results From the Intensive Care Over Nations Audit.

Sakr Y, Alhussami I, Nanchal R, Wunderink RG, Pellis T, Wittebole X, Martin-Loeches I, François B, Leone M, Vincent JL; Intensive Care Over Nations Investigators..

Crit Care Med. 2015 Dec;43(12):2623-32. doi: 10.1097/CCM.0000000000001310.

PMID:
26427591
8.

Lost signature: progress and failures in in vivo tracking of implanted stem cells.

von der Haar K, Lavrentieva A, Stahl F, Scheper T, Blume C.

Appl Microbiol Biotechnol. 2015 Dec;99(23):9907-22. doi: 10.1007/s00253-015-6965-7. Review.

PMID:
26373727
9.

Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study.

Hoste EA, Bagshaw SM, Bellomo R, Cely CM, Colman R, Cruz DN, Edipidis K, Forni LG, Gomersall CD, Govil D, Honoré PM, Joannes-Boyau O, Joannidis M, Korhonen AM, Lavrentieva A, Mehta RL, Palevsky P, Roessler E, Ronco C, Uchino S, Vazquez JA, Vidal Andrade E, Webb S, Kellum JA.

Intensive Care Med. 2015 Aug;41(8):1411-23. doi: 10.1007/s00134-015-3934-7.

PMID:
26162677
10.

Evaluation of the biological tolerability of the starch-based medical device 4DryField® PH in vitro and in vivo a rat model.

Poehnert D, Abbas M, Maegel L, Sambale F, Lavrentieva A, Kreipe HH, Klempnauer J, Winny M.

J Biomater Appl. 2015 Oct;30(4):463-71. doi: 10.1177/0885328215592257.

PMID:
26116021
11.

Nonelective surgery at night and in-hospital mortality: Prospective observational data from the European Surgical Outcomes Study.

van Zaane B, van Klei WA, Buhre WF, Bauer P, Boerma EC, Hoeft A, Metnitz P, Moreno RP, Pearse R, Pelosi P, Sander M, Vallet B, Pettilä V, Vincent JL, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology..

Eur J Anaesthesiol. 2015 Jul;32(7):477-85. doi: 10.1097/EJA.0000000000000256.

PMID:
26001104
12.

Critical care of burn patients. New approaches to old problems.

Lavrentieva A.

Burns. 2016 Feb;42(1):13-9. doi: 10.1016/j.burns.2015.04.009. Review.

PMID:
25997751
13.

Potential and limitations of microscopy and Raman spectroscopy for live-cell analysis of 3D cell cultures.

Charwat V, Schütze K, Holnthoner W, Lavrentieva A, Gangnus R, Hofbauer P, Hoffmann C, Angres B, Kasper C.

J Biotechnol. 2015 Jul 10;205:70-81. doi: 10.1016/j.jbiotec.2015.02.007. Review.

PMID:
25687101
14.

Coagulopathy in burn patients: one part of a deadly trio.

Lavrentieva A.

Burns. 2015 May;41(3):419-20. doi: 10.1016/j.burns.2014.11.009. No abstract available.

PMID:
25681959
15.

Three dimensional spheroid cell culture for nanoparticle safety testing.

Sambale F, Lavrentieva A, Stahl F, Blume C, Stiesch M, Kasper C, Bahnemann D, Scheper T.

J Biotechnol. 2015 Jul 10;205:120-9. doi: 10.1016/j.jbiotec.2015.01.001.

PMID:
25595712
16.

Hydrogels for 3D mammalian cell culture: a starting guide for laboratory practice.

Ruedinger F, Lavrentieva A, Blume C, Pepelanova I, Scheper T.

Appl Microbiol Biotechnol. 2015 Jan;99(2):623-36. doi: 10.1007/s00253-014-6253-y. Review.

PMID:
25432676
17.

End-of-life decisions in Burn Intensive Care Units - An International Survey.

Metaxa V, Lavrentieva A.

Burns. 2015 Feb;41(1):53-7. doi: 10.1016/j.burns.2014.05.018.

PMID:
25017109
18.

Diagnostic value of procalcitonin in burn septic patients.

Lavrentieva A.

Burns. 2014 Sep;40(6):1239-40. doi: 10.1016/j.burns.2014.03.023. No abstract available.

PMID:
24951119
19.

Enteral nutrition intolerance in critically ill septic burn patients.

Lavrentieva A, Kontakiotis T, Bitzani M.

J Burn Care Res. 2014 Jul-Aug;35(4):313-8. doi: 10.1097/BCR.0b013e3182a22403.

PMID:
24879397
20.

Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit.

Vincent JL, Marshall JC, Namendys-Silva SA, François B, Martin-Loeches I, Lipman J, Reinhart K, Antonelli M, Pickkers P, Njimi H, Jimenez E, Sakr Y; ICON investigators..

Lancet Respir Med. 2014 May;2(5):380-6. doi: 10.1016/S2213-2600(14)70061-X.

PMID:
24740011
Items per page

Supplemental Content

Loading ...
Support Center